A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy.

Trial Profile

A Korean Open-label, Multi-center, Community-based Trial Assessing the Efficacy and Safety of Zonisamide as Adjunctive Therapy in Patients With Uncontrolled Partial Epilepsy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 26 Apr 2017

At a glance

  • Drugs Zonisamide (Primary)
  • Indications Partial epilepsies
  • Focus Therapeutic Use
  • Sponsors Eisai Korea
  • Most Recent Events

    • 07 Sep 2011 Actual initiation date change from Sep 2007 to Feb 2008 as reported by ClinicalTrials.gov.
    • 12 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 16 Jun 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top